Meghmani Organics Past Earnings Performance
Past criteria checks 0/6
Meghmani Organics's earnings have been declining at an average annual rate of -50.1%, while the Chemicals industry saw earnings growing at 14.3% annually. Revenues have been declining at an average rate of 13.9% per year.
Key information
-50.1%
Earnings growth rate
-50.1%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | -13.9% |
| Return on equity | -5.5% |
| Net Margin | -4.8% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Meghmani Organics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 17,196 | -822 | 1,139 | 0 |
| 30 Jun 24 | 15,544 | -883 | 1,152 | 0 |
| 31 Mar 24 | 15,663 | -1,060 | 1,169 | 0 |
| 31 Dec 23 | 17,303 | -339 | 1,202 | 0 |
| 30 Sep 23 | 19,280 | 127 | 1,201 | 0 |
| 30 Jun 23 | 21,950 | 942 | 1,194 | 0 |
| 31 Mar 23 | 25,526 | 2,377 | 1,308 | 0 |
| 31 Dec 22 | 27,904 | 2,858 | 1,313 | 0 |
| 30 Sep 22 | 28,812 | 3,458 | 1,319 | 0 |
| 30 Jun 22 | 27,837 | 3,449 | 1,324 | 0 |
| 31 Mar 22 | 24,985 | 3,044 | 1,208 | 0 |
| 31 Dec 21 | 21,497 | 2,382 | 1,134 | 0 |
| 30 Sep 21 | 19,572 | 2,258 | 1,126 | 0 |
| 30 Jun 21 | 18,357 | 2,261 | 1,108 | 0 |
| 31 Mar 21 | 16,367 | 1,865 | 1,030 | 0 |
| 31 Mar 20 | 13,991 | 2,991 | 780 | 0 |
| 31 Mar 19 | 20,880 | 2,513 | 1,281 | 0 |
| 31 Mar 18 | 18,033 | 1,713 | 1,031 | 0 |
| 31 Mar 17 | 14,229 | 877 | 686 | 0 |
| 31 Mar 16 | 13,322 | 825 | 765 | 0 |
Quality Earnings: 543331 is currently unprofitable.
Growing Profit Margin: 543331 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 543331 is unprofitable, and losses have increased over the past 5 years at a rate of 50.1% per year.
Accelerating Growth: Unable to compare 543331's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 543331 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (6.7%).
Return on Equity
High ROE: 543331 has a negative Return on Equity (-5.48%), as it is currently unprofitable.